LORAZEPAM IMPURITY D(54699-91-1)
- Name: LORAZEPAM IMPURITY D
- Synonyms:Lorazepam specified impurity D [EP];1H-1,4-Benzodiazepine-2,3-dione,7-chloro-5-(2-chlorophenyl)-4,5-dihydro;7-chloro-5-(2-chlorophenyl)-2,3-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine;7-Chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione,(+/-);7-chloro-5-(2-chloro-phenyl)-4,5-dihydro-1H-benzo[e][1,4]diazepine-2,3-dione;(5RS)-7-Chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione;7-Chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione,(5RS);
- Molecular Formula:C15H10Cl2N2O2
- Molecular Weight:321.15800
- CAS Registry Number:54699-91-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.54699-91-1 LORAZEPAM IMPURITY D
Assay:99%min. Appearance:Colorless liquid Package:1kg/Export worthy packing; 25kg/drum Storage:In well-closed container, protected from light and in cool & dry place. Transportation:By Air, By Sea, By courier (door to door, DHL/FedEx/UPS) Application:R&D and production for pharmaceuticals and chemicals
Min. Order:0
Supplier:LIDE PHARMACEUTICALS LIMITED [
China (Mainland)] CAS No.54699-91-1 Lorazepam EP Impurity D
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.54699-91-1 7-Chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 54690-69-6/Silane, cyclopropyltrimethoxy-
- 54690-75-4/1,3-Propanediol, 2-(6-amino-9H-purin-9-yl)-, bis(dihydrogen phosphate) (ester)
- 54690-76-5/1,4-Butanediol, 2-(6-amino-9H-purin-9-yl)-, bis(dihydrogen phosphate) (ester)
- 54692-49-8/Ethanone, 1-phenyl-, peroxide
- 54695-19-1/2-Butanone, 4-phenyl-4-(1-piperidinyl)-
- 54696-07-0/1-Propanone, 1-(4-methoxy-2-methylphenyl)-2-methyl-
- 54696-23-0/Propanoic acid, 3-[(4-chlorophenyl)thio]-, methyl ester
- 54696-28-5/Bicyclo[3.3.1]nonane-3,7-dicarboxylic acid, 2,6-dioxo-, dimethyl ester
- 54696-33-2/Glycine, N-(carboxymethyl)-N-[(7-hydroxy-2-oxo-2H-1-benzopyran-8-yl)methyl]-
- 54696-40-1/3H-Xanthen-3-one, 9,9'-(1,4-phenylene)bis[2,6,7-trihydroxy-
- 54696-56-9/Ethanedione, bis(2,4-dichlorophenyl)-
- 54697-23-3/1,3-Cyclopentanedicarboxylic acid, 4-oxo-, diethyl ester
- 54698-12-3/1H-Indole, 1-(acetyloxy)-
- 54698-36-1/2-Heptenoic acid, 7-[[(4-methylphenyl)sulfonyl]oxy]-, methyl ester, (2E)-
- 54698-69-0/1,3-Benzenedibutanoic acid, dimethyl ester
- 54698-75-8/1,3-Benzenedibutanoic acid
- 54699-20-6/[(Ethoxymethyl)thio]ethane
- 54699-39-7/9-Methoxy-3-nonyne
- 54699-41-1/9-[(Tetrahydro-2H-pyran-2-yl)oxy]-2-nonanone
- 54699-91-1/LORAZEPAM IMPURITY D
- 54700-04-8/4(1H)-Pyrimidinone, 2,6-diamino-5-[(3,4,5-trimethoxyphenyl)methyl]-, monohydrochloride
- 54700-47-9/Hydrazinecarboxylic acid, (2-naphthalenylmethylene)-, ethyl ester
- 54701-96-1/Spiro[bicyclo[2.2.1]heptane-2,2'-[1,3]dioxolane], 7-methyl-7-[4-methyl-1-[(4-methylphenyl)sulfonyl]-3-pentenyl]-
- 54702-64-6/2-Cyclohexen-1-one, 3-[(1Z)-2-(4-nitrophenyl)ethenyl]-
- 54702-74-8/Borinic acid, diphenyl-, 2-[(methylimino)methyl]phenyl ester
- 54702-75-9/Borinic acid, diphenyl-, 2-[(ethylimino)methyl]phenyl ester
- 54702-76-0/Borinic acid, diphenyl-, 2-[(hexylimino)methyl]phenyl ester
- 54702-77-1/Borinic acid, diphenyl-, 2-[(octylimino)methyl]phenyl ester
- 54702-78-2/Borinic acid, diphenyl-, 2-[(decylimino)methyl]phenyl ester
- 54703-48-9/Benzene, (1-ethoxy-3-butenyl)-